Manufacturing cell therapies is technically and financiallydemanding; as a result, despite therapy developers gradually strengtheningtheir in-house expertise, they are also becoming increasingly reliant on contractservice providers
Roots Analysis is pleased toannounce the publication of its recent study, titled, “Cell Therapy Manufacturing Market (3rd Edition),2019 - 2030”.”
Thereport features an extensive study of the current market landscape and futureopportunities associated with cell therapy manufacturing. It focuses on bothcontract manufacturers, as well as developers with in-house manufacturingfacilities, offering in-depth analyses of the various business entities thatare engaged in this domain, across different global regions. Amongst otherelements, the report includes:
§ Ananalysis of the various expansion initiatives undertaken by service providers,in order to augment their respective cell therapy manufacturing capabilities,over the period 2015-2019.
§ Ananalysis of the recent partnerships focused on the manufacturing of cell-basedtherapies, which have been established in the period 2014-2019.
§ Informedestimates of the annual commercial and clinical demand for cell therapies, interms of number of cells produced and area dedicated to manufacturing.
§ Anestimate of the overall, installed capacity for manufacturing cell-basedtherapies based on information reported by industry stakeholders in the publicdomain A competitiveness analysis of biological targets, featuring insightfulpictorial summaries and representations.
§ A detailed analysis of the various factors that are likelyto influence the pricing of cell-based therapies, featuring different models /approaches that may be adopted by manufacturers while deciding the prices oftheir proprietary offerings.
§ A qualitativeanalysis, highlighting the various factors that need to be taken intoconsideration by cell therapy developers while deciding whether to manufacturetheir respective products in-house or engage the services of a CMO.
§ Anelaborate discussion on the role of automation technologies in improvingcurrent manufacturing methods.
§ A discussion on celltherapy manufacturing regulations across various geographies, including NorthAmerica, Europe, and Asia Pacific.
§ Elaborate profiles of key players (industry andnon-industry) that offer contract manufacturing services.
§ A discussion on affiliated trends, key drivers andchallenges, which are likely to impact the industry’s evolution, under acomprehensive SWOT framework.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Typeof therapy
§ T-celltherapies (CAR-T therapies, TCR therapies, TIL therapies)
§ Dendriticcell therapies
§ Tumorcell therapies
§ NKcell therapies
§ Stemcell therapies
§ Source of cells
§ Autologous
§ Allogeneic
§ Scaleof operation
§ Clinical
§ Commercial
§ Purposeof manufacturing
§ Contract manufacturing
§ In-house manufacturing
§ Keygeographical regions
§ North America
§ Europe
§ Asia Pacific
§ Rest of the world
Keycompanies covered in the report
§ BioNTech Innovative Manufacturing Services
§ Cell Therapies
§ Cell and Gene Therapy Catapult
§ Center for Cell and Gene Therapy, Baylor College ofMedicine
§ Centre for Cell Manufacturing Ireland, National Universityof Ireland
§ Clinical Cell and Vaccine Production Facility, Universityof Pennsylvania
§ Cognate BioServices
§ FUJIFILM
§ Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
§ Hitachi Chemical
§ KBI Biopharma
§ Laboratory for Cell and Gene Medicine, Stanford University
§ Lonza
§ MaSTherCell
§ MEDINET
§ Molecular and Cellular Therapeutics, University ofMinnesota
§ Newcastle Cellular Therapies Facility, Newcastle University
§ Nikon CeLL innovation
§ Rayne Cell Therapy Suite, King’s College London
§ Roslin Cell Therapies
§ Scottish National Blood Transfusion Services CellularTherapy Facility, Scottish Centre for Regenerative Medicine
§ Sydney Cell and Gene Therapy
§ WuXi Advanced Therapies
For additionaldetails, please visit
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.htmloremail sales@rootsanalysis.com
You may also beinterested in the following titles:
1. Celland Advanced Therapies Supply Chain ManagementMarket, 2019-2030
2. RNAiTherapeutics Market (2nd Edition), 2019 – 2030
3. GeneTherapy Market (3rd Edition), 2019 – 2030
4. StemCell Therapy Contract Manufacturing Market, 2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
